Format

Send to

Choose Destination
Ann Allergy Asthma Immunol. 2016 Feb;116(2):106-11. doi: 10.1016/j.anai.2015.10.012. Epub 2015 Oct 27.

Counseling patients with asthma and allergy about electronic cigarettes: an evidence-based approach.

Author information

1
Centro per la Prevenzione e Cura del Tabagismo, Azienda Ospedaliero-Universitaria "Policlinico V. Emanuele", Catania, Italy; Dipartimento di Medicina Clinica e Sperimentale, Università di Catania, Catania, Italy; UOC di Medicina Interna e d'Urgenza, Azienda Ospedaliero-Universitaria "Policlinico V. Emanuele", Catania, Italy. Electronic address: polosa@unict.it.
2
Centro per la Prevenzione e Cura del Tabagismo, Azienda Ospedaliero-Universitaria "Policlinico V. Emanuele", Catania, Italy; Dipartimento di Medicina Clinica e Sperimentale, Università di Catania, Catania, Italy; UOC di Medicina Interna e d'Urgenza, Azienda Ospedaliero-Universitaria "Policlinico V. Emanuele", Catania, Italy.
3
Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York; The Veterans Administration Healthcare System of Western New York, Buffalo, New York.

Abstract

OBJECTIVE:

To provide an evidence-based review of common safety concerns and emerging potential benefits deriving from the regular use of electronic cigarettes (ECs) and thus improve counseling between physicians and their patients with asthma and allergy using or intending to use ECs.

DATA SOURCES:

Peer-reviewed articles from the National Center for Biotechnology Information's PubMed about ECs, risk reduction, and harm reversal were appraised.

STUDY SELECTION:

Keywords used in the search were smoking cessation, electronic cigarette, counseling, asthma, allergy, nicotine, tobacco harm reduction, and harm reversal.

RESULTS:

Vapor toxicology is far less problematic compared with combustible cigarettes, with exclusive EC users having substantial lower risk of exposure to tobacco smoke toxicants and carcinogens compared with cigarette smokers. Moreover, there is emerging evidence that switching to regular EC use could produce significant respiratory health gains.

CONCLUSION:

Inaccurate and inconsistent information about EC safety and efficacy, tobacco harm reduction, and nicotine toxicity is being offered to smokers and EC users. In particular, most health care professionals cannot communicate a clear and consistent message to their patients with respiratory problems and allergy who use or intend to use ECs. Therefore, it is important for the medical community to take an active role in considering all the pathways available to a smoking patient and recommend those that provide the greatest probability of eliminating exposure to tobacco smoke, including ECs.

PMID:
26522253
DOI:
10.1016/j.anai.2015.10.012
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center